von Bueren, A O <br/><br/>
Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91.  [electronic resource] 

 -  Klinische Padiatrie   
 - 396-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1439-3824 
<br/><br/><label>Standard No.: </label>10.1055/s-0029-1238278  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age Factors<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cerebellar Neoplasms--drug therapy<br/>Child<br/>Child, Preschool<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Lomustine--administration & dosage<br/>Male<br/>Medulloblastoma--drug therapy<br/>Neoadjuvant Therapy<br/>Nervous System Diseases--chemically induced<br/>Prospective Studies<br/>Radiotherapy, Adjuvant<br/>Risk Factors<br/>Vincristine--administration & dosage